Synthetic small interfering RNA targeting heat shock protein 105 induces apoptosis of various cancer cells both in vitro and in vivo

Cancer Science

Volumn 97, Issue 7, 2006, Pages 623-632

  Hosaka, Seiji ^a   Nakatsura, Tetsuya ^a,d   Tsukamoto, Hirotake ^a   Hatayama, Takumi ^c   Baba, Hideo ^b   Nishimura, Yasuharu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; DOXORUBICIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 105; PROTEIN P53; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER THERAPY; CELL PROTECTION; CELL STRAIN 3T3; COLON CANCER; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG TARGETING; FIBROBLAST; GENE OVEREXPRESSION; GENE REPRESSION; HEAT SHOCK; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; MALIGNANT TRANSFORMATION; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH CANCER; WILD TYPE;

ANIMALS; APOPTOSIS; CASPASES; CELL LINE, TUMOR; DOXORUBICIN; DRUG SYNERGISM; FIBROBLASTS; HEAT; HSP110 HEAT-SHOCK PROTEINS; HUMANS; MICE; NEOPLASMS; NIH 3T3 CELLS; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33745956840     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2006.00217.x     Document Type: Article

References (43)

1. Lee-Yoon D, Easton D, Murawski M, Burd R, Subjeck JR. Identification of a major subfamily of large hsp70-like proteins through the cloning of the mammalian 110-kDa heat shock protein. J Biol Chem 1995; 270: 15 725-33.
2. Yasuda K, Nakai A, Hatayama T, Nagata K. Cloning and expression of murine high molecular mass heat shock proteins, HSP105. J Biol Chem 1995; 270: 29 718-23.
3. Wakatsuki T, Hatayama T. Characteristic expression of 105-kDa heat shock protein (HSP105) in various tissues of non-stressed and heat-stressed rats. Biol Pharm Bull 1998; 21: 905-10.
4. Satoh J, Yukitake M, Kuroda Y. Constitutive and heat-inducible expression of HSP105 in neurons and glial cells in culture. Neuroreport 1998; 9: 2977-83.
5. Ishihara K, Yasuda K, Hatayama T. Molecular cloning, expression and localization of human 105 kDa heat shock protein, hsp105. Biochim Biophys Acta 1999; 1444: 138-42.
6. Yamagishi N, Nishihori H, Ishihara K, Ohtsuka K, Hatayama T. Modulation of the chaperone activities of Hsc70/Hsp40 by Hsp105α and Hsp105β. Biochem Biophys Res Commun 2000; 272: 850-5.
7. Yamagishi N, Ishihara K, Saito Y, Hatayama T. Hsp105 but not Hsp70 family proteins suppress the aggregation of heat-denatured protein in the presence of ADP. FEBS Lett 2003; 555: 390-6.
8. Hatayama T, Yamagishi N, Minobe E, Sakai K. Role of hsp105 in protection against stress-induced apoptosis in neuronal PC12 cells. Biochem Biophys Res Commun 2001; 288: 528-34.
9. Ishihara K, Yamagishi N, Saito Y et al. Hsp105α suppresses the aggregation of truncated androgen receptor with expanded CAG repeats and cell toxicity. J Biol Chem 2003; 278: 25 143-50.
10. Hatayama T, Takigawa T, Takeuchi S, Shiota K. Characteristic expression of high molecular mass heat shock protein HSP105 during mouse embryo development. Cell Struct Funct 1997; 22: 517-25.
11. Evrard L, Vanmuylder N, Dourov N, Glineur R, Louryan S. Cytochemical identification of HSP110 during early mouse facial development. J Craniofac Genet Dev Biol 1999; 19: 24-32.
12. Yamagishi N, Ishihara K, Saito Y, Hatayama T. Hsp105α enhances stress-induced apoptosis but not necrosis in mouse embryonal F9 cells. J Biochem (Tokyo) 2002; 132: 271-8.
13. Yamagishi N, Saito Y, Ishihara K, Hatayama T. Enhancement of oxidative stress-induced apoptosis by Hsp105α in mouse embryonal F9 cells. Eur J Biochem 2002; 269: 4143-51.
14. Nakatsura T, Senju S, Yamada K, Jotsuka T, Ogawa M, Nishimura Y. Gene cloning of immunogenic antigens overexpressed in pancreatic cancer. Biochem Biophys Res Commun 2001; 281: 936-44.
15. Kai M, Nakatsura T, Egami H, Senju S, Nishimura Y, Ogawa M. Heat shock protein 105 is overexpressed in a variety of human tumors. Oncol Rep 2003; 10: 1777-82.
16. Hwang TS, Han HS, Choi HK et al. Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer. J Gastroenterol Hepatol 2003; 18: 690-700.
17. Yang G, Thompson JA, Fang B, Liu J. Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumor growth in a model of human ovarian cancer. Oncogene 2003; 22: 5694-701.
18. Gaggar A, Shayakhmetov DM, Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med 2003; 9: 1408-12.
19. Wilson JA, Jayasena S, Khvorova A et al. RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc Natl Acad Sci USA 2003; 100: 2783-8.
20. Takei Y, Kadomatsu K, Yuzawa Y, Matsuo S, Muramatsu T. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res 2004; 64: 3365-70.
21. Chae SS, Paik JH, Furneaux H, Hla T. Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. J Clin Invest 2004; 114: 1082-9.
22. Monji M, Senju S, Nakatsura T et al. Head and neck cancer antigens recognized by the humoral immune system. Biochem Biophys Res Commun 2002; 294: 734-41.
23. Nogawa M, Yuasa T, Kimura S et al. Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer. J Clin Invest 2005; 115: 978-85.
24. King FW, Wawrzynow A, Höhfeld J, Zylicz M. Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53. EMBO J 2001; 20: 6297-305.
25. JäätteläM, Wissing D, Bauer PA, Li GC. Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. EMBO J 1992; 11: 3507-12.
26. Mosser DD, Caron AW, Bourget L, Denis-Larose C, Massie B. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol 1997; 17: 5317-27.
27. Jättelä M, Wissing D, Kokholm K, Kallunki T, Egeblad M. Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J 1998; 17: 6124-34.
28. Ciocca DR, Clark GM, Tandon AK, Fuqua SA, Welch WJ, McGuire WL. Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: Prognostic implications. J Natl Cancer Inst 1993; 85: 570-4.
29. Lazaris A, Chatzigianni EB, Panoussopoulos D, Tzimas GN, Davaris PS, Golematis B. Proliferating cell nuclear antigen and heat shock protein 70 immunolocalization in invasive ductal breast cancer not otherwise specified. Breast Cancer Res Treat 1997; 43: 43-51.
30. Vargas-Roig LM, Fanelli MA, López LA et al. Heat shock proteins and cell proliferation in human breast cancer biopsy samples. Cancer Detect Prev 1997; 21: 441-51.
31. Vargas-Roig LM, Gago FE, Tello O, Aznar JC, Ciocca DR. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer 1998; 79: 468-75.
32. Oh HJ, Chen X, Subjeck JR. Hsp110 protects heat-denatured proteins and confers cellular thermoresistance. J Biol Chem 1997; 272: 31 636-40.
33. Nylandsted J, Rohde M, Brand K, Bastholm L, Elling F, Jäättelä M. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci USA 2000; 97: 7871-6.
34. Helmbrecht K, Zeise E, Rensing L. Chaperones in cell cycle regulation and mitogenic signal transduction: A review. Cell Prolif 2000; 33: 341-65.
35. Walerych D, Kudla G, Gutkowska M et al. Hsp90 chaperones wild-type p53 tumor suppressor protein. J Biol Chem 2004; 279: 48 836-45.
36. Whitesell L, Sutphin PD, Pulcini EJ, Martinez JD, Cook PH. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent. Mol Cell Biol 1998; 18: 1517-24.
37. Welihinda AA, Tirasophon W, Kaufman RJ. The cellular response to protein misfolding in the endoplasmic reticulum. Gene Expr 1999; 7: 293-300.
38. Nakagawa T, Zhu H, Morishima N et al. Caspase-12 mediates endoplasmic reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000; 403: 98-103.
39. Momoi T. Caspases involved in ER stress-mediated cell death. J Chem Neuroanat 2004; 28: 101-5.
40. Kakimura J, Kitamura Y, Takata K et al. Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. FASEB J 2002; 16: 601-3.
41. Verma UN, Surabhi RM, Schmaltieg A, Becerra C, Gaynor RB. Small interfering RNAs directed against β-catenin inhibit the in vitro and in vivo growth of colon cancer cells. lin Cancer Res 2003; 9: 1291-300.
42. Brummelkamp TR, Bernards R, Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002; 2: 243-7.
43. Wilda M, Fuchs U, Wössmann W, Borkhardt A. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 2002; 21: 5716-24.